| SSP037 Estraderm MX® 50mcg patches substitution (PDF:214KB) |
15 Nov 2022 to 13 Jan 2023
This SSP was withdrawn early on 23 Nov 2022
|
Estraderm MX® 50mcg supporting guidance plus Q&A (PDF:114KB) |
| SSP036 Estraderm MX® 100mcg patches (PDF:214KB) |
08 Sep 2022 to 14 Oct 2022 |
Estraderm MX® 100mcg supporting guidance plus Q&A (PDF:115KB) |
| SSP035 Estraderm MX® 25mcg patches (PDF:213KB) |
08 Sep 2022 to 14 Oct 2022 |
Estraderm MX® 25mcg supporting guidance plus Q&A (PDF:114KB) |
| SSP034 Combisal® 125mcg/25mcg inhalers (PDF:146KB) |
22 Jul 2022 to 7 Oct 2022
|
Combisal® 125mcg/25mcg inhalers supporting guidance plus Q&A (PDF:153KB) |
| SSP033 Paracetamol 120mg suppositories (PDF:139KB) |
31 May 2022 to 26 Aug 2022 |
Paracetamol 120mg suppositories supporting guidance plus Q&A (PDF:111KB) |
| SSP032 Atorvastatin (Lipitor®) 10mg chewable tablets (PDF:145KB) |
31 May 2022 to 9 Sep 2022
|
Atorvastatin (Lipitor®) 10mg chewable tablets supporting guidance plus Q&A (PDF:117KB) |
| SSP025 Estriol (Ovestin® 1mg cream) 0.1% cream substitution and restriction (PDF:228KB) |
19 May 2022 to 30 Nov 2022
|
Ovestin® supporting guidance plus Q&A (PDF:152KB) |
| SSP024 Estriol (Ovestin® 1mg cream) 0.1% cream substitution (PDF:226KB) |
19 May 2022 to 30 Nov 2022
|
Ovestin® supporting guidance plus Q&A (PDF:133KB) |
| SSP023 Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution and restriction (PDF:751KB) |
19 May 2022 to 30 Nov 2022
|
Oestrogel® supporting guidance plus Q&A (PDF:150KB) |
| SSP022 Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution (PDF:750KB) |
19 May 2022 to 30 Nov 2022
|
Oestrogel® supporting guidance plus Q&A (PDF:149KB) |
| SSP021 Premique® low dose 0.3mg/1.5mg modified-release tablets (PDF:166KB) |
29 Apr 2022 to 29 Jul 2022 |
Premique® low dose supporting guidance plus Q&A (PDF:122KB) |
| SSP020 Ovestin® 1mg cream restriction (PDF:166KB) |
29 Apr 2022 to 30 Nov 2022
|
Ovestin® supporting guidance plus Q&A (PDF:122KB) |
| SSP019 Oestrogel® Pump-Pack 0.06% gel restriction (PDF:167KB) |
29 Apr 2022 to 30 Nov 2022
|
Oestrogel® supporting guidance plus Q&A (PDF:125KB) |
| SSP018 Salazopyrin® 500mg tablets (PDF:244KB) |
16 Mar 2022 to 25 Mar 2022 |
Salazopyrin® supporting guidance plus Q&A (PDF:112KB) |
| SSP017 Atorvastatin (Lipitor®) 20mg chewable tablets (PDF:122KB) |
15 Feb 2022 to 5 Apr 2022
|
Atorvastatin supporting guidance plus Q&A (PDF:111KB) |
| SSP016 Atorvastatin (Lipitor®) 10mg chewable tablets (PDF:123KB) |
15 Feb 2022 to 18 Mar 2022
|
Atorvastatin supporting guidance plus Q&A (PDF:111KB) |
| SSP015 Paracetamol 120mg and 240mg suppositories (PDF:124KB) |
25 Jan 2022 to 4 Mar 2022
|
Paracetamol supporting guidance plus Q&A (PDF:111KB) |
| SSP014 Salazopyrin® 500mg EN tablets (PDF:160KB) |
28 Feb 2022 to 1 Apr 2022
This SSP was reactivated. |
Salazopyrin® EN supporting guidance plus Q&A (PDF:111KB) |
| SSP014 Salazopyrin® 500mg EN tablets (PDF:160KB) |
26 Nov 2021 to 21 Jan 2022
|
Salazopyrin® EN supporting guidance plus Q&A (PDF:135KB) |
| SSP013 Atorvastatin (Lipitor®) 20mg chewable tablets (PDF:211KB) |
18 Nov 2021 to 12 Jan 2022 |
Atorvastatin supporting guidance plus Q&A (PDF: 134KB) |
| SSP012 Estradot® 75microgram patches (PDF:204KB) |
29 Apr 2021 to 11 Jun 2021
|
Estradot® supporting guidance plus Q&A (PDF: 120KB) |
| SSP011 Competact 15mg/850mg tablets (PDF:170KB) |
24 Mar 2021 to 14 May 2021
|
Competact supporting guidance plus Q&A (PDF: 113KB) |
| SSP010 Levothyroxine 12.5microgram tablets (PDF:143KB) |
3 Feb 2021 to 1 Apr 2021
|
Levothyroxine supporting guidance plus Q&A (PDF: 111KB) |
| SSP009 Fluoxetine 40mg capsules (PDF:139KB) |
29 Jan 2021 to 17 May 2021
|
Fluoxetine supporting guidance plus Q&A (PDF: 111KB) |
| SSP008 Salazopyrin 500mg EN tablets (PDF:151KB) |
20 Oct 2020 to 8 Mar 2021
|
Salazopyrin EN supporting guidance plus Q&A (PDF: 130KB) |
| SSP007 Fluoxetine 30mg capsules (PDF:144KB) |
20 Oct 2020 to 28 Jul 2021
|
Fluoxetine supporting guidance plus Q&A (PDF: 142KB) |
| SSP06 Fluoxetine 40mg capsules (PDF:135KB) |
20 May 2020 to 2 Oct 2020 |
Fluoxetine supporting guidance plus Q&A (PDF: 111KB) |
| SSP04 Haloperidol (Serenace) 500 microgram (mcg) capsules (PDF:107KB) |
23 Dec 2019 to 23 Mar 2020 |
Haloperidol supporting guidance plus Q&A (PDF:125KB) |
| SSP03 Fluoxetine 40mg capsules (PDF:131KB) |
3 Oct 2019 to 20 Nov 2019
|
Fluoxetine supporting endorsement guidance (PDF: 139KB) |
| SSP02 Fluoxetine 30mg capsules (PDF:124KB) |
3 Oct 2019 to 18 Dec 2019
This SSP has been varied - the revised end date is now 18 Dec 19, and supply in accordance with this SSP is now
1 x 10mg Fluoxetine capsule PLUS 1 x 20mg Fluoxetine capsule.
|
Fluoxetine supporting endorsement guidance (PDF: 139KB) |
| SSP01 Fluoxetine 10mg capsules (PDF:151KB) |
3 Oct 2019 to 25 Oct 2019
|
Fluoxetine supporting endorsement guidance (PDF: 139KB) |
